Efficacy of Rifaximin vs Norfloxacin for Secondary Prophylaxis of SBP (NORRIF Trial)

Conditions: Spontaneous Bacterial Peritonitis Interventions: Drug: Rifaximin; Drug: Norfloxacin Sponsors: Institute of Liver and Biliary Sciences, India Not yet recruiting

https://clinicaltrials.gov/study/NCT06199843

Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials